Charles C Dai (Chuankai Dai)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Monoclonal Antibody

Top Venues

ACS infectious diseases

Drug delivery and translational research

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Queensland Jan 09 2017

Australia

PHD :: School of Chemistry & Molecular Biosciences

University of Queensland Feb 07 2017 - Dec 14 2017

Australia

BSC :: School of Chemistry & Molecular Biosciences

University of Queensland Feb 20 2013 - Jul 20 2017

Australia

BSC :: School of Chemistry & Molecular Biosciences

Publications

Frazer Sinclair, Anjuman A Begum, Charles C Dai, Istvan Toth, Peter Michael Moyle
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing. Drug delivery and translational research (2023)
Frazer Sinclair, Anjuman A Begum, Charles C Dai, Istvan Toth, Peter Michael Moyle
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing. Drug delivery and translational research (2023)
Farjana Khatun, Charles C Dai, Tania Rivera-Hernandez, Waleed M Hussein, Zeinab G Khalil, Robert J Capon, Istvan Toth, Rachel J Stephenson
Immunogenicity Assessment of Cell Wall Carbohydrates of Group A Streptococcus via Self-Adjuvanted Glyco-lipopeptides. ACS infectious diseases 7 (2) (2021)
Charles C Dai, Zeinab G Khalil, Waleed M Hussein, Jieru Yang, Xiumin Wang, Lili Zhao, Robert J Capon, Istvan Toth, Rachel J Stephenson
Opsonic Activity of Conservative Versus Variable Regions of the Group A Streptococcus M Protein. Vaccines 8 (2) (2020)
Charles C Dai, Jieru Yang, Waleed M Hussein, Lili Zhao, Xiumin Wang, Zeinab G Khalil, Robert J Capon, Istvan Toth, Rachel J Stephenson
Polyethylenimine: An Intranasal Adjuvant for Liposomal Peptide-Based Subunit Vaccine against Group A Streptococcus. ACS infectious diseases 6 (9) (2020)